Your browser doesn't support javascript.
loading
Gemcitabine plus concurrent irreversible electroporation vs gemcitabine alone for locally advanced pancreatic cancer.
Ma, Yang-Yang; Leng, Yin; Xing, Yan-Li; Li, Hong-Mei; Chen, Ji-Bing; Niu, Li-Zhi.
Afiliação
  • Ma YY; Central Laboratory, Affiliated Fuda Cancer Hospital, Jinan University, Guangzhou 510665, Guangdong Province, China.
  • Leng Y; Department of Oncology, Affiliated Fuda Cancer Hospital, Jinan University, Guangzhou 510665, Guangdong Province, China.
  • Xing YL; Department of Oncology, Affiliated Fuda Cancer Hospital, Jinan University, Guangzhou 510665, Guangdong Province, China.
  • Li HM; Department of Oncology, Affiliated Fuda Cancer Hospital, Jinan University, Guangzhou 510665, Guangdong Province, China.
  • Chen JB; Central Laboratory, Affiliated Fuda Cancer Hospital, Jinan University, Guangzhou 510665, Guangdong Province, China.
  • Niu LZ; Department of Interventional Radiology, Affiliated Fuda Cancer Hospital, Jinan University, Guangzhou 510665, Guangdong Province, China. niuboshi@fudahospital.com.
World J Clin Cases ; 8(22): 5564-5575, 2020 Nov 26.
Article em En | MEDLINE | ID: mdl-33344547
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Revista: World J Clin Cases Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Revista: World J Clin Cases Ano de publicação: 2020 Tipo de documento: Article